These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8020721)

  • 1. [Stimulation of the release of factor VIII and von Willebrand factor into the plasma of donors and the cryoprecipitate].
    Elykomov VA; Tsalikhin AD; Barkagan ZS
    Gematol Transfuziol; 1993 Feb; 38(2):40-1. PubMed ID: 8020721
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.
    Konecka G; Bykowska K; Ludwicka A; Letowska M; Wegrzynowicz Z; Sablinski J; Lopaciuk S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desmopressin on plasma factor VIII and von Willebrand factor concentrations in Greyhounds.
    Sato I; Parry BW
    Aust Vet J; 1998 Dec; 76(12):809-12. PubMed ID: 9972432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand disease.
    Zimmerman TS; Ruggeri ZM
    Hum Pathol; 1987 Feb; 18(2):140-52. PubMed ID: 3100416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
    Brenner B; Seligsohn U; Hochberg Z
    J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced yield of antihemophilic factor and von Willebrand factor by cryoprecipitation with polyethylene glycol.
    Johnson AJ; Macdonald VE; Brind J
    Vox Sang; 1979; 36(2):72-6. PubMed ID: 313629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
    Cattaneo M; Simoni L; Gringeri A; Mannucci PM
    Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
    Castaman G; Eikenboom JC; Contri A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):351-2. PubMed ID: 10959713
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.
    Perret BA; Furlan M; Beck EA
    Haemostasis; 1984; 14(4):289-95. PubMed ID: 6437941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
    Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
    Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
    Bala L; Boggio L; Green D
    Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical application of DDVP on hemophiliacs].
    Kobayashi I; Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):975-86. PubMed ID: 6818810
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of multimeric structure and ristocetin-induced binding to platelets of von Willebrand factor present in cryoprecipitate and different factor VIII concentrates.
    López-Fernández MF; López-Berges C; Corral M; García-Talavera JR; López Borrasca A; Batlle J
    Vox Sang; 1987; 52(1-2):15-9. PubMed ID: 3111088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of von Willebrand factor and factor VIII in canine cryoprecipitate under various conditions of storage.
    Stokol T; Parry BW
    Res Vet Sci; 1995 Sep; 59(2):152-5. PubMed ID: 8525105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.
    Porta M
    Diabetologia; 1982 Nov; 23(5):452-5. PubMed ID: 6816652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dispersity of human factor VIII--Von Willebrand factor.
    van Mourik JA; Bolhuis PA
    Thromb Res; 1978 Jul; 13(1):15-24. PubMed ID: 308712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.